午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Bulk Drug Intermediates>Ozagrel sodium
Ozagrel sodium
  • Ozagrel sodium
  • Ozagrel sodium
  • Ozagrel sodium

Ozagrel sodium

Price Get Latest Price
Package 1kg 25kg
Min. Order: 1kg
Supply Ability: 500kg
Update Time: 2025-03-04

Product Details

Product Name: Ozagrel sodium CAS No.: 130952-46-4
Min. Order: 1kg Purity: 0.99
Supply Ability: 500kg Release date: 2025/03/04

?? ?Product Overview?
?Ozagrel Sodium? (CAS: 130952-46-4) is a selective thromboxane A2 synthase inhibitor widely recognized for its antiplatelet activity, effectively preventing thrombus formation in cardiovascular conditions such as acute ischemic stroke and peripheral arterial occlusion. With a molecular formula of ?C??H??N?NaO?? and molecular weight of ?250.23?, this compound reduces platelet aggregation by over 80% in clinical studies. It is a critical component in ?pharmaceutical manufacturing?, ?clinical therapy?, and ?cardiovascular research?, supporting advanced treatments for thrombotic disorders.

? ?Key Advantages?
?? ?High Efficacy?: Clinically proven to reduce platelet aggregation by >80%.
?? ?Premium Quality?: ≥98% purity (HPLC/GC-certified), compliant with USP/EP standards.
?? ?Stability?: Stable under ambient storage with long-term shelf life.
?? ?Structural Verification?: Confirmed by NMR, MS, and chromatographic analysis.

?? ?Applications?
? ?Pharmaceuticals?: Key intermediate in antiplatelet drug formulations.
? ?Clinical Use?: Approved for ischemic stroke and thrombosis management.
? ?Research?: Investigated for neuroprotective and anti-inflammatory properties.

?? ?Quality Certifications?
? Complies with ?USP/EP? guidelines for impurities, heavy metals, and residual solvents.
? Batch-specific COA includes purity (≥98%), pH (8.0–9.5), and moisture content (≤0.5%).
? Rigorous testing via HPLC (>95% purity), NMR, and mass spectrometry.

?? ?Market Trends?
The global cardiovascular drug market is projected to grow at ?5.2% CAGR (2025–2030)?, driven by rising thrombosis and stroke prevalence. Ozagrel Sodium holds a significant share in antiplatelet APIs, with expanding demand in Asia-Pacific and Europe.

?Google Keywords?: Ozagrel Sodium CAS 130952-46-4, cardiovascular API, antiplatelet agent, USP/EP certified, pharmaceutical supplier.


Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/25kg
PNP Biotech Co. Ltd
2022-10-20
$150.00/1kg
Hebei Mingeng Biotechnology Co., Ltd
2022-05-05
$0.00/10mg
Guangzhou PI PI BIOTECH INC
2021-09-18
$100.00/1ASSAYS
Hebei Minshang Biological Technology Co. LTD
2021-05-21
$3.00/1KG
VIP6Y
Career Henan Chemical Co
2020-01-07
  • Since: 2018-06-08
  • Address: Biolake.858 high-tech avenue,Wuhan
INQUIRY

+86-+undefined-+86 13343427080
sales@biocarchem.com